The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

Bradford B. Worrall, MD, a University of Virginia professor of neurology and public health, says many stroke survivors develop spasticity.

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

Brendan Carr, the President Trump-appointed FCC chairman, warned the CEOs of PBS and NPR that they “could be violating ...

Vertex has gained the FDA's approval for its non-addictive pain med Journavx, which becomes the first significant innovation ...

Dr. Terry Dubrow is one of the best plastic surgeons for a good reason, and Brandi Glanville has learned to trust him. Newly ...

Living with chronic, persistent pain is a fact of life for 3 out of 10 people in the U.S. What people would give up to reduce ...

At Stiiizy, the bestselling cannabis brand in America, the goal is explicit: producing powerful and cheap marijuana.

After an overnight fast during bedtime, our bodies need breakfast to refuel and function at our best. The best combination is ...